FIELD: chemistry.
SUBSTANCE: invention relates to camsilate and maleate salts of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one and to a pharmaceutical composition having activity which is mediated by poly(ADP-ribose)polymerase (PARP), which contains a therapeutically effective amount of the disclosed salt.
EFFECT: obtaining camsilate and maleate salts of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one, having high hydration resistance.
15 cl, 38 dwg, 31 tbl, 31 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CRYSTALLINE SOLID FORMS OF 6-CARBOXY-2-(3,5-DICHLOROPHENYL)BENZOXAZOLE | 2015 |
|
RU2692252C2 |
| CRYSTALLINE FORMS OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREA MALEATE | 2016 |
|
RU2717564C2 |
| CRYSTALLINE FORMS OF 6-[2-(METHYLCARBAMOYL)PHENYLSULFANYL]-3-E-[2-(PYRIDIN-2-YL)ETHENYL]INDAZOLE, SUITABLE FOR TREATMENT OF ABNORMAL GROWTH OF CELLS IN MAMMALS | 2008 |
|
RU2518898C2 |
| SOLID FORMS OF TRANSTHYRETIN DISSOCIATION INHIBITOR | 2012 |
|
RU2586330C2 |
| SALTS AND POLYMORPHIC MODIFICATIONS OF THE INHIBITOR VEGF-R | 2006 |
|
RU2369607C1 |
| SOLID FORMS OF SELECTIVE CDK4/6 INHIBITOR | 2014 |
|
RU2619944C2 |
| POLYMORPHIC FORM | 2009 |
|
RU2448966C1 |
| FORM VI OF ATORVASTATIN CALCIUM AND ITS HYDRATES | 2002 |
|
RU2294924C2 |
| MOTILIDE POLYMORPHS | 2007 |
|
RU2422453C2 |
| POLYMORPHOUS AND AMORPHOUS FORMS OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINE[5,4,3-CD]INDOL-6-ON PHOSPHATE | 2005 |
|
RU2355691C2 |
